Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Conditions:   Hormone-Resistant Prostate Cancer;   Stage IV Prostate AdenocarcinomaInterventions:   Drug: Cabazitaxel;   Drug: PrednisoneSponsors:   University of California, Davis;   SanofiNot yet recruiting - verified July 2016

Source: ClinicalTrials.gov - June 28, 2016 Category: Research Source Type: clinical trials